Regeneration or Risk? A Narrative Review of BPC 157 for Musculoskeletal Healing Current Reviews in Musculoskeletal Medicine Springer Nature Link Is BPC 157 Banned? Oral vs. Injectable Forms Explained September 8, 2025: FDA launches an import alert listing safe GLP 1 manufacturers Partnership for Safe Medicines The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA's Legislative Request on Rx and Compounded Drug Advertising Coalition for Healthcare Communication